Track the access landscape in Latin America by examining medicine spending over the last five years and standout examples of ongoing initiatives founded by pharmaceutical companies to improve access in the region.

This infographic examines how the pharmaceutical industry’s R&D pipeline is evolving, looking at the companies leading the way and factors behind the recent uptick in IRR.

In the wake of COVID-19, GOLD investigates the potential impact of unpredictable events on the industry’s complex distribution network to understand its resilience and vulnerability.

The mRNA COVID-19 vaccine took only a year to develop – beating the previous fastest traditional vaccine development, held by the 1967 mumps vaccine, of four years. How does it differ from traditional vaccine technology?

This infographic explores pharmaceutical trade patterns globally, ranking the top importing and exporting countries, spotlighting the manufacturing hotspots to watch, and investigating the impact of COVID-19 on rates of trade internationally.

This infographic tracks the evolution of the industry’s reputation by breaking down the perspectives of individual countries and generations, while also examining the impact of the COVID-19 pandemic on public outlook.

This infographic reviews drug launches from recent years, comparing the expectation vs reality of launch, the increase in first-time launchers, and the impact of COVID-19 on the landscape.

We consider the multi-functional uses and potential of biotechnology, highlight some of the biggest players in biotech, and forecast how the market could ascend in the coming years.